ViroGates A/S (CPH:VIRO)

ViroGates Statistics

Total Valuation

ViroGates has a market cap or net worth of DKK 76.73 million. The enterprise value is 69.89 million.

Market Cap	76.73M
Enterprise Value	69.89M

Important Dates

The last earnings date was Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

ViroGates has 7.73 million shares outstanding. The number of shares has increased by 20.01% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	+20.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.61%
Owned by Institutions (%)	n/a
Float	2.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.16
PB Ratio	16.10
P/TBV Ratio	16.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.51
EV / Sales	7.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 1.06.

Current Ratio	1.92
Quick Ratio	1.61
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.21

Financial Efficiency

Return on equity (ROE) is -180.17% and return on invested capital (ROIC) is -63.99%.

Return on Equity (ROE)	-180.17%
Return on Assets (ROA)	-46.04%
Return on Invested Capital (ROIC)	-63.99%
Return on Capital Employed (ROCE)	-143.79%
Revenue Per Employee	1.34M
Profits Per Employee	-1.81M
Employee Count	10
Asset Turnover	0.55
Inventory Turnover	0.80

Taxes

Income Tax	-638,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.74% in the last 52 weeks. The beta is 1.05, so ViroGates's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+78.74%
50-Day Moving Average	10.62
200-Day Moving Average	10.02
Relative Strength Index (RSI)	49.25
Average Volume (20 Days)	1,507

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViroGates had revenue of DKK 9.40 million and -12.69 million in losses. Loss per share was -1.64.

Revenue	9.40M
Gross Profit	6.76M
Operating Income	-12.50M
Pretax Income	-13.32M
Net Income	-12.69M
EBITDA	n/a
EBIT	-12.50M
Loss Per Share	-1.64

Balance Sheet

The company has 11.88 million in cash and 5.05 million in debt, giving a net cash position of 6.83 million or 0.88 per share.

Cash & Cash Equivalents	11.88M
Total Debt	5.05M
Net Cash	6.83M
Net Cash Per Share	0.88
Equity (Book Value)	4.77M
Book Value Per Share	0.62
Working Capital	8.52M

Cash Flow

Operating Cash Flow	-4.73M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 71.98%, with operating and profit margins of -133.06% and -135.00%.

Gross Margin	71.98%
Operating Margin	-133.06%
Pretax Margin	-141.79%
Profit Margin	-135.00%
EBITDA Margin	n/a
EBIT Margin	-133.06%
FCF Margin	n/a

Dividends & Yields

ViroGates does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.01%
Shareholder Yield	n/a
Earnings Yield	-16.53%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ViroGates has an Altman Z-Score of 1.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.54
Piotroski F-Score	3